A phase II randomized placebo-controlled study of fisetin and exercise to mitigate chemotherapy-related functional decline in postmenopausal women with early breast cancer (PROFFi).Jingran Ji, Mina S. Sedrak, Yuliya Zektser et al.|Journal of Clinical Oncology|2025Cited by 2